It is reported in the existing literature that the incidence of EGFR mutation is higher in Asian nonsmoking females with lung adenocarcinoma; KRAS mutation is associated with smoking, which is more common in male patients with lung adenocarcinoma; and ALK and ROS1 fusion mutations have higher frequency in nonsmoking young patients. The gene discussed is EGFR; the disease is lung adenocarcinoma.